Market revenue in 2024 | USD 12.4 million |
Market revenue in 2030 | USD 23.7 million |
Growth rate | 11.5% (CAGR from 2025 to 2030) |
Largest segment | Dystonia |
Fastest growing segment | Epilepsy |
Historical data | 2018 - 2023 |
Base year | 2024 |
Forecast period | 2025 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Pain Management, Epilepsy, Essential Tremor, Obsessive Compulsive Disorder (OCD), Parkinsons Disease, Depression, Dystonia |
Key market players worldwide | Abbott Laboratories, Medtronic PLC, Boston Scientific Corp, Nexstim Oyj Registered Shs Reg S, LivaNova PLC, NeuroPace Inc |
Dystonia was the largest segment with a revenue share of 71.77% in 2024. Horizon Databook has segmented the South Korea deep brain stimulation devices market based on pain management, epilepsy, essential tremor, obsessive compulsive disorder (ocd), parkinsons disease, depression, dystonia covering the revenue growth of each sub-segment from 2018 to 2030.
South Korea is expected to grow at a considerably faster rate in the coming years owing to rising prevalence of neurological disorders such as PD, epilepsy, and brain tumors. PD, epilepsy, and other neurological disorders are age related, thus rise in geriatric population would lead to increase in the incidence of such conditions, thereby creating more opportunities in deep brain stimulation devices market.
Furthermore, Korea-US Free Trade Agreement (KORUS FTA) was implemented on March 15, 2012, thus, most of the medical devices in Korea received duty-free treatment. Moreover, mental health awareness programs are being conducted by many nonprofit organizations and institutions such as Department of Neurology (Y.S.K.), among others.
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account